Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR‐T

Patients with relapsed follicular lymphoma who do not respond to CAR‐T have a poor outcome. We present a case of refractory follicular lymphoma who relapsed after two CAR‐T infusions and achieved a complete remission after treatment with obinutuzumab and lenalidomide. This represents a promising tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kase, Adam M., Kharfan‐Dabaja, Mohamed A., Donaldson, Andrew, Elliott, Jamie, Sher, Taimur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991760/
https://www.ncbi.nlm.nih.gov/pubmed/35425600
http://dx.doi.org/10.1002/ccr3.5572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991760/
https://www.ncbi.nlm.nih.gov/pubmed/35425600
http://dx.doi.org/10.1002/ccr3.5572

Ejemplares similares